Publication: 179

Publication: 179

Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 28 (13) 2137-43

Year:: 2010
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 497 698
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:
Grants:: CA14985, CA33601, CA41287, U10 CA077202, U10 CA045808, U10 CA031946, U10 CA033601, CA60138, CA45808, U10 CA077440, CA77440, U10 CA041287, CA77202, CA47642, U10 CA047642, CA31946

Corr. Author:
Authors:: Brian I. Rini Susan Halabi Jonathan E. Rosenberg Walter M. Stadler Daniel A. Vaena Laura Archer James N. Atkins Joel Picus Piotr Czaykowski Janice Dutcher Eric J. Small

Networks:

Study: CALGB-90206
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Guc19, Original Reports, Genitourinary Cancer